Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
59
-
Total shares
-
13M
-
Shares change
-
+163K
-
Total reported value, excl. options
-
$101M
-
Value change
-
+$1.43M
-
Put/Call ratio
-
0.43
-
Number of buys
-
20
-
Number of sells
-
-26
-
Price
-
$7.74
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q3 2016
64 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q3 2016.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13M shares
.
Largest 10 shareholders include Wildcat Capital Management, LLC (2.8M shares), Cormorant Asset Management, LLC (2.12M shares), venBio Select Advisor LLC (1.53M shares), VANGUARD GROUP INC (1.52M shares), BlackRock Fund Advisors (691K shares), BlackRock Institutional Trust Company, N.A. (613K shares), STATE STREET CORP (486K shares), NORTHERN TRUST CORP (378K shares), GEODE CAPITAL MANAGEMENT, LLC (353K shares), and FRANKLIN RESOURCES INC (339K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.